Abstract:Endothelial dysfunction predisposing to cardiovascular diseases is defined as an imbalance in the production of vasodilating factors, such as nitric oxide (NO), and vasoconstrictive factors. To insure its physiological role, NO, a radical with very short half-life, requires to be stored and transported to its action site. S-nitrosothiols (RSNOs) like S-nitrosoglutathione (GSNO) represent the main form of NO storage within the vasculature. The NO store formed by RSNOs is still bioavailable to trigger vasorelaxation. In this way, RSNOs are an emerging class of NO donors with a potential to restore NO bioavailability within cardiovascular disorders. The aim of this study was to compare S-nitrosothiols ability, formed of peptide (glutathione) like the physiologic GSNO or derived from amino acids (cysteine, valine) like the synthetics S-nitroso-N-acetylcysteine (NACNO) and S-nitroso-N-acetylpenicillamine (SNAP), respectively, to produce a vascular store of NO either in endothelium-intact or endothelium-removed aortae in order to evaluate whether RSNOs can be used as therapeutics to compensate endothelial dysfunction. Sodium nitroprusside (SNP), a marketed drug already in clinics, was used as a non-RSNO NO-donor. Endothelium-intact or endothelium-removed aortae, isolated from normotensive Wistar rats, were exposed to RSNOs or SNP. Then, NO-derived (NOx) species, representing the NO store inside the vascular wall, were quantified using the diaminonaphthalene probe coupled to mercuric ions. The bioavailability of the NO store and its ability to induce vasodilation was tested using N-acetylcysteine, then its ability to counteract vasoconstriction was challenged using phenylephrine (PHE). All the studied RSNOs were able to generate a NO store materialized by a three to five times increase in NOx species inside aortae. NACNO was the most potent RSNO to produce a vascular NO store bioavailable for vasorelaxation and the most efficient to induce vascular hyporeactivity to PHE in endothelium-removed aortae. GSNO and SNAP were equivalent and more efficient than SNP. In endothelium-intact aortae, the NO store was also formed whereas it seemed less available for vasorelaxation and did not influence PHE-induced vasoconstriction. In conclusion, RSNOs - NACNO in a better extent - are able to restore NO bioavailability as a functional NO store within the vessel wall, especially when the endothelium is removed. This was associated with a hyporeactivity to the vasoconstrictive agent phenylephrine. Treatment with RSNOs could present a benefit to restore NO-dependent functions in pathological states associated with injured endothelium.

Effects of Sodium Nitroprusside on Lipopolysaccharide-Induced Inflammation and Disruption of Blood-Brain Barrier

Sodium Nitroprusside Decreased Leukotriene C4 Generation by Inhibiting Leukotriene C4 Synthase Expression and Activity in Hepatic Ischemia-Reperfusion Injured Rats.

Sodium Nitroprusside Regulates Mrna Expressions of LTC4 Synthesis Enzymes in Hepatic Ischemia/Reperfusion Injury Rats Via NF-κB Signaling Pathway

Sodium Nitroprusside Protects HFD Induced Gut Dysfunction Via Activating AMPKα/SIRT1 Signaling

Effects of Sodium Nitroprusside (SNP) on CD14 in U937 Cells Induced by Lipopolysaccharide

Effects of antioxidants and NO on TNF-α-induced adhesion molecule expression in human pulmonary microvascular endothelial cells

Sodium nitroprusside restored lipopolysaccharide-induced learning and memory impairment in male rats via attenuating inflammation and oxidative stress

Effect of NO donor sodium nitroprusside on lipopolysaccharide induced acute lung injury in rats

Protective effect of panaxydol and panaxynol on sodium nitroprusside-induced apoptosis in cortical neurons.

A Mechanism for Effects of Nitric Oxide Donors on LPS-induced Pulmonary Oedema

[Influence of Intracerebroventricular Injection of Sodium Nitroprusside L-arginine and NG-nitro-L-arginine on Cardiovascular Activity in Conscious Rats].

Mechanism of Protective Effect of Sodium Nitroprusside Against Endotoxin-Induced Acute Lung Injury in Rats

Oxidative and adhesive responses of human neutrophils to nitrovasodilators in vitro: the role of protein kinases

Early NO-donor treatment improves acute perfusion deficit and brain damage after experimental subarachnoid hemorrhage in rats

Role of sodium nitroprusside in regulating retinal ganglion cell damage through mitochondrial transcription factor A

Paracrine signalling of inflammatory cytokines from an in vitro blood brain barrier model upon exposure to polymeric nanoparticles

Biphasic Regulation of P-glycoprotein Function and Expression by NO Donors in Caco-2 Cells

S-Nitrosothiols as potential therapeutics to induce a mobilizable vascular store of nitric oxide to counteract endothelial dysfunction

Role of nitric oxide in inflammation-mediated neurodegeneration.

NOSH-NBP, a Novel Nitric Oxide and Hydrogen Sulfide- Releasing Hybrid, Attenuates Ischemic Stroke-Induced Neuroinflammatory Injury by Modulating Microglia Polarization

Beneficial Effect of Sodium Nitrite on EEG Ischaemic Markers in Patients with Subarachnoid Haemorrhage